Heparanase: A Novel Therapeutic Target for the Treatment of Atherosclerosis
Cardiovascular disease (CVD) is the leading cause of death and disability worldwide, and its management places a huge burden on healthcare systems through hospitalisation and treatment. Atherosclerosis is a chronic inflammatory disease of the arterial wall resulting in the formation of lipid-rich, f...
Main Authors: | Tien K. Nguyen, Stephanie Paone, Enoch Chan, Ivan K. H. Poon, Amy A. Baxter, Shane R. Thomas, Mark D. Hulett |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-10-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/11/20/3198 |
Similar Items
-
The Heparanase Regulatory Network in Health and Disease
by: Alyce J. Mayfosh, et al.
Published: (2021-10-01) -
Heparanase: A Multitasking Protein Involved in Extracellular Matrix (ECM) Remodeling and Intracellular Events
by: Valentina Masola, et al.
Published: (2018-11-01) -
Emerging Roles of Heparanase in Viral Pathogenesis
by: Neel Thakkar, et al.
Published: (2017-09-01) -
Acute T-Cell-Driven Inflammation Requires the Endoglycosidase Heparanase-1 from Multiple Cell Types
by: Zuopeng Wu, et al.
Published: (2022-04-01) -
The Potential Impact of Heparanase Activity and Endothelial Damage in COVID-19 Disease
by: Elisabeth Zechendorf, et al.
Published: (2022-09-01)